Related Experiment Video
Updated: May 19, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Severe Hyperammonemic Encephalopathy Following Sustained-Release Sodium Valproate Overdose: A Case Report
Shotaro Ban1, Chiaki Toida2, Maiko Yamazaki1
1Emergency Medicine, Teikyo University School of Medicine, Tokyo, JPN.
Valproate overdose can cause severe hyperammonemia and encephalopathy. Hemodialysis and L-carnitine are crucial for managing these serious complications, especially with high drug concentrations.
Area of Science:
- Neurology
- Clinical Toxicology
- Pharmacology
Background:
- Valproate-induced hyperammonemia is a known adverse effect.
- Severe hyperammonemic encephalopathy is a rare but life-threatening complication of valproate overdose.
Related Concept Videos
Hepatic Encephalopathy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmaceutical Poisoning: Treatment Strategies
Antiepileptic Drugs: Glutamate Antagonists
Pharmaceutical Poisoning: Potential Scenarios
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
